Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis. [electronic resource]
Producer: 19990903Description: 338-43 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Antiemetics -- adverse effects
- Antineoplastic Agents -- adverse effects
- Benzene Derivatives -- adverse effects
- Cisplatin -- adverse effects
- Dexamethasone -- therapeutic use
- Double-Blind Method
- Female
- Granisetron -- therapeutic use
- Humans
- Male
- Middle Aged
- Neurokinin-1 Receptor Antagonists
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.